MMSI - メリット・メディカル・システムズ （Merit Medical Systems Inc.） メリット・メディカル・システムズMMSIのチャート
MMSIの企業情報
| symbol | MMSI |
|---|---|
| 会社名 | Merit Medical Systems Inc. （メリット・メディカル・システムズ） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Medical/Dental Instruments |
| 業種 | 医療機器_医療用品_ディストリビュ―タ― 医療関連（Health Care） |
| 概要 | 事業概要 メリット・メディカル・システムズ（Merit Medical Systems Inc.）は各種の介入・診断・治療手順用使い捨て医療機器の製造・販売を行う。同社は心臓血管事業と内視鏡検査事業の2つの事業を運営する。心臓血管事業は冠状動脈疾病、末梢血管疾病及び他の非血管性疾病の診断・治療を支持する心臓学と放射線装置、並びに塞栓治療、心臓リズム管理（CRM）、電気生理学（EP）および介入腫瘍治療および スパインデバイスを含む。内視鏡検査事業は悪性腫瘍に原因する食道の拡大、気管と気管支・胆汁狭窄の緩和治療を支持する胃腸病学と肺臓学医療装置を提供する。同社は末梢介入、心臓介入、介入腫瘍学と脊柱、内視鏡検査という4つの製品グループに焦点を当てた製品を提供する。 メリット・メディカル・システムズは、米国の医療機器製造業者。診断で使用する医療機器の開発、製造、販売を行う。心臓病・放射線学分野にて冠動脈疾患、末梢血管疾患の診断と治療に塞栓術療法の製品を提供。また消化器・呼吸器分野にて悪性腫瘍に起因する食道・気管気管支・胆道狭窄の拡大の緩和治療に使う内視鏡などの医療機器を手掛ける。 Founded in 1987, Merit Medical Systems, Inc. is a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy. Merit serves client hospitals worldwide with a domestic and international sales force and clinical support team totaling in excess of 500 individuals. Merit employs approximately 6,000 people worldwide with facilities in South Jordan, Utah; Pearland, Texas; Richmond, Virginia; Rockland, Massachusetts; Aliso Viejo, California; Maastricht and Venlo, The Netherlands; Paris, France; Galway, Ireland; Beijing, China; Tijuana, Mexico; Joinville, Brazil; Ontario, Canada; Melbourne, Australia; Tokyo, Japan; Reading, United Kingdom; Johannesburg, South Africa; and Singapore. |
| 本社所在地 | 1600 West Merit Parkway South Jordan UT 84095 USA |
| 代表者氏名 | Fred P. Lampropoulos フレッドP.ランポロプロス |
| 代表者役職名 | Chairman of the Board President Chief Executive Officer 取締役会長兼最高経営責任者（CEO） |
| 電話番号 | +1 801-253-1600 |
| 設立年月日 | 31959 |
| 市場名 | NASDAQ National Market System |
| ipoyear | ―年 |
| 従業員数 | 4876人 |
| url | www.merit.com |
| nasdaq_url | https://www.nasdaq.com/symbol/mmsi |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） 99.64400 |
| 終値（lastsale） | 64.12 |
| 時価総額（marketcap） | 3509639362.32 |
| 時価総額 | 時価総額（百万ドル） 3433.01 |
| 売上高 | 売上高（百万ドル） 798.07900 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 3803.065 |
| 当期純利益 | 当期純利益（百万ドル） 21.64700 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 Merit Medical Systems Inc. revenues increased 20% to $427.8M. Net income decreased 33% to $16.2M. Revenues reflect Cardiovascular segment increase of 20% to $412.2M Endoscopy segment increase of 19% to $15.6M. Basic Earnings per Share excluding Extraordinary Items decreased from $0.52 to $0.32. |
MMSIのテクニカル分析
MMSIのニュース
Merit Medical Systems to Announce First Quarter 2023 Results on April 26, 2023 2023/04/06 13:25:00 GlobeNewswire
SOUTH JORDAN, Utah, April 06, 2023 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the quarter ended March 31, 2023, after the close of the stock market on Wednesday, April 26, 2023.
Catheter Introducer Sheaths Market Size to Cross USD 1.6 Bn by 2031 | Transparency Market Research 2023/03/20 18:33:00 Accesswire
WILMINGTON, DE / ACCESSWIRE / March 20, 2023 / Transparency Market Research Inc. - The global catheter introducer sheaths market was valued at USD 1.0 Bn in 2022 and is projected to reach USD 1.6 Bn by 2031 with CAGR of 5.3%. Increase in prevalence of cardiovascular diseases, advances in medical technology, surge in awareness about cardiac conditions and treatments, government support for the development of new products, and expanding geriatric population are some key factors fueling the catheter introducer sheaths market. Catheter introducer sheaths are mostly used during interventional procedures that require access to the cardiovascular system. These provide a stable pathway to introduce other medical devices into blood vessels. Request for a Sample PDF Report with Latest Industry Insights: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85444 Advances in medical technology is anticipated to create new revenue streams, and thus fuel business growth. Rise in development of new catheter sheaths, which lower the risk of contamination, help reduce procedure time, are easy to use, and provide improved patient comfort and safety, are anticipated to propel market development.
Merit Medical Launches Expanded SwiftNINJA® Steerable Microcatheter Offering 2023/03/20 13:25:00 GlobeNewswire
New sizes of advanced articulating microcatheter enhance a market-leading portfolio of vascular access products New sizes of advanced articulating microcatheter enhance a market-leading portfolio of vascular access products
Merit Medical Launches Expanded SwiftNINJA Steerable Microcatheter Offering 2023/03/20 13:25:00 Wallstreet:Online
New sizes of advanced articulating microcatheter enhance a market-leading portfolio of vascular access products SOUTH JORDAN, Utah, March 20, 2023 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced the expansion of its SwiftNINJA Steerable Microcatheter product line. New sizes include a low-profile
Chief Operating Officer at Merit Medical Systems Acquires Company Stock Options Worth 13,576 Shares 2023/03/03 15:01:15 Benzinga
Neil Peterson , Chief Operating Officer at Merit Medical Systems (NASDAQ: MMSI ), reported a large acquisition of company stock options on March 2, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Thursday showed that Peterson, Chief Operating Officer at Merit Medical Systems, a company in the Health Care sector, was just awarded stock options worth 13,576 shares of MMSI. The options give Peterson the right to buy the company''s stock at $70.58 per share. Merit Medical Systems shares are trading down 0.11% at $69.8 at the time of this writing on Friday morning. Since the current price is $69.8, this makes … Full story available on Benzinga.com
Merit Medical Systems to Announce First Quarter 2023 Results on April 26, 2023 2023/04/06 13:25:00 GlobeNewswire
SOUTH JORDAN, Utah, April 06, 2023 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the quarter ended March 31, 2023, after the close of the stock market on Wednesday, April 26, 2023.
Catheter Introducer Sheaths Market Size to Cross USD 1.6 Bn by 2031 | Transparency Market Research 2023/03/20 18:33:00 Accesswire
WILMINGTON, DE / ACCESSWIRE / March 20, 2023 / Transparency Market Research Inc. - The global catheter introducer sheaths market was valued at USD 1.0 Bn in 2022 and is projected to reach USD 1.6 Bn by 2031 with CAGR of 5.3%. Increase in prevalence of cardiovascular diseases, advances in medical technology, surge in awareness about cardiac conditions and treatments, government support for the development of new products, and expanding geriatric population are some key factors fueling the catheter introducer sheaths market. Catheter introducer sheaths are mostly used during interventional procedures that require access to the cardiovascular system. These provide a stable pathway to introduce other medical devices into blood vessels. Request for a Sample PDF Report with Latest Industry Insights: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85444 Advances in medical technology is anticipated to create new revenue streams, and thus fuel business growth. Rise in development of new catheter sheaths, which lower the risk of contamination, help reduce procedure time, are easy to use, and provide improved patient comfort and safety, are anticipated to propel market development.
Merit Medical Launches Expanded SwiftNINJA® Steerable Microcatheter Offering 2023/03/20 13:25:00 GlobeNewswire
New sizes of advanced articulating microcatheter enhance a market-leading portfolio of vascular access products New sizes of advanced articulating microcatheter enhance a market-leading portfolio of vascular access products
Merit Medical Launches Expanded SwiftNINJA Steerable Microcatheter Offering 2023/03/20 13:25:00 Wallstreet:Online
New sizes of advanced articulating microcatheter enhance a market-leading portfolio of vascular access products SOUTH JORDAN, Utah, March 20, 2023 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced the expansion of its SwiftNINJA Steerable Microcatheter product line. New sizes include a low-profile
Chief Operating Officer at Merit Medical Systems Acquires Company Stock Options Worth 13,576 Shares 2023/03/03 15:01:15 Benzinga
Neil Peterson , Chief Operating Officer at Merit Medical Systems (NASDAQ: MMSI ), reported a large acquisition of company stock options on March 2, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Thursday showed that Peterson, Chief Operating Officer at Merit Medical Systems, a company in the Health Care sector, was just awarded stock options worth 13,576 shares of MMSI. The options give Peterson the right to buy the company''s stock at $70.58 per share. Merit Medical Systems shares are trading down 0.11% at $69.8 at the time of this writing on Friday morning. Since the current price is $69.8, this makes … Full story available on Benzinga.com
Merit Medical Systems, Inc. (MMSI) Fred Lampropoulos on Q3 2022 Results - Earnings Call Transcript 2022/10/27 03:15:02 Seeking Alpha
Merit Medical Systems, Inc. (NASDAQ:NASDAQ:MMSI) Q3 2022 Earnings Conference Call October 26, 2022 05:00 PM ET Company Participants Fred Lampropoulos - President & CEO Brian Lloyd -…
Merit Medical Systems: Q3 Earnings Insights 2022/10/26 21:04:03 Benzinga
Merit Medical Systems (NASDAQ: MMSI ) reported its Q3 earnings results on Wednesday, October 26, 2022 at 04:05 PM. Here''s what investors need to know about the announcement. Earnings Merit Medical Systems beat estimated earnings by 20.75%, reporting an EPS of $0.64 … Full story available on Benzinga.com
Merit Medical Systems Non-GAAP EPS of $0.64 beats by $0.11, revenue of $287.2M beats by $14.66M 2022/10/26 20:32:54 Seeking Alpha
Merit Medical Systems press release (MMSI): Q3 Non-GAAP EPS of $0.64 beats by $0.11.Revenue of $287.2M (+7.6% Y/Y) beats by $14.66M.Shares +2.6%.Fiscal Year 2022 Financial…
Merit Medical Systems to Announce Third Quarter Results on October 26, 2022 2022/10/13 13:25:00 GlobeNewswire
SOUTH JORDAN, Utah, Oct. 13, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the quarter ended September 30, 2022, after the close of the stock market on Wednesday, October 26, 2022.
Merit Medical Launches the TEMNO Elite Soft Tissue Biopsy System 2022/09/27 13:25:00 Wallstreet:Online
Advanced device offers 72% larger samples, simplifies tissue retrieval, and enhances patient safety SOUTH JORDAN, Utah, Sept. 27, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced U.S. commercial release of the TEMNO Elite Soft Tissue Biopsy System, the latest addition to Merit’s comprehensive